about
Implementing ecopharmacovigilance in practice: challenges and potential opportunitiesOutcomes of the California ban on pharmaceutical lindane: clinical and ecologic impactsOverview of Emerging Contaminants and Associated Human Health EffectsMicroextraction techniques coupled to liquid chromatography with mass spectrometry for the determination of organic micropollutants in environmental water samplesStatus of hormones and painkillers in wastewater effluents across several European states-considerations for the EU watch list concerning estradiols and diclofenacZebrafish: A Model for the Study of Toxicants Affecting Muscle Development and FunctionEuropean regulation affecting nanomaterials - review of limitations and future recommendationsOccurrence and abundance of antibiotics and resistance genes in rivers, canal and near drug formulation facilities--a study in PakistanAre pharmaceuticals with evolutionary conserved molecular drug targets more potent to cause toxic effects in non-target organisms?Metabolomics Analysis Reveals the Participation of Efflux Pumps and Ornithine in the Response of Pseudomonas putida DOT-T1E Cells to Challenge with PropranololIdentification of Putative Nuclear Receptors and Steroidogenic Enzymes in Murray-Darling Rainbowfish (Melanotaenia fluviatilis) Using RNA-Seq and De Novo Transcriptome Assembly.Global synthesis and critical evaluation of pharmaceutical data sets collected from river systemsUse of acute and chronic ecotoxicity data in environmental risk assessment of pharmaceuticals.Hepatic proteome sensitivity in rainbow trout after chronically exposed to a human pharmaceutical verapamil.Microbial biotransformation of furosemide for environmental risk assessment: identification of metabolites and toxicological evaluation.Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA National Sewage Sludge Survey.Photochemical transformation of the thyroid hormone levothyroxine in aqueous solution.Meeting report: pharmaceuticals in water-an interdisciplinary approach to a public health challenge.Molecular and microscopic assessment of the effects of caffeine, acetaminophen, diclofenac, and their mixtures on river biofilm communities.Conservation and divergence of chemical defense system in the tunicate Oikopleura dioica revealed by genome wide response to two xenobioticsEcotoxicological effects of ciprofloxacin on freshwater species: data integration and derivation of toxicity thresholds for risk assessment.Pharmaceuticals as neuroendocrine disruptors: lessons learned from fish on Prozac.Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms.Biodegradation of ofloxacin, norfloxacin, and ciprofloxacin as single and mixed substrates by Labrys portucalensis F11.Behavioural ecotoxicology, an "early warning" signal to assess environmental qualityEffects of the veterinary pharmaceutical ivermectin in indoor aquatic microcosmsToxicological effects of the antibiotic oxytetracycline to an Indian major carp Labeo rohita.Diclofenac: New data on chronic toxicity and bioconcentration in fishNeural tube defects in mice exposed to tap water.Cyclic-AMP mediated regulation of ABCB mRNA expression in mussel haemocytesCommunity interactions modify the effects of pharmaceutical exposure: a microcosm study on responses to propranolol in Baltic Sea coastal organismsProfiling hepatic microRNAs in zebrafish: fluoxetine exposure mimics a fasting response that targets AMP-activated protein kinase (AMPK)Adsorption in a Fixed-Bed Column and Stability of the Antibiotic Oxytetracycline Supported on Zn(II)-[2-Methylimidazolate] Frameworks in Aqueous Media.Molecular and Cellular Effects Induced in Mytilus galloprovincialis Treated with Oxytetracycline at Different Temperatures.Human pharmaceuticals in the marine environment: Focus on exposure and biological effects in animal species.Aerobic degradation of ibuprofen in batch and continuous reactors by an indigenous bacterial community.Effects of pharmaceuticals and personal care products on marine organisms: from single-species studies to an ecosystem-based approach.Non-genomic effects of xenoestrogen mixtures.Impact of anti-inflammatories, beta-blockers and antibiotics on leaf litter breakdown in freshwaters.
P2860
Q24608788-8AE28B69-494C-4EE3-B501-A98EFBD58442Q24656540-ECEBEC0A-5B9B-4C98-888B-E82E26A35C1BQ26771705-2710DFFE-4B82-4CCD-868F-08231E247D2EQ26851885-F6AA8B7C-71F1-4B2F-A252-B2FD041B5CE3Q27313821-1442240C-8F15-48F2-9E7A-3D96DC19A19FQ28078475-760C8945-3D5E-453C-9958-AFE7FABB8853Q28387964-AEC2A5C8-18C1-4A15-B6E6-6BAB796AD0F4Q28534402-73E99666-E53F-44B4-BD8A-B1CCFF46383FQ28542416-7E775A10-1DBE-4782-BCA1-0E58423D5EA4Q28552021-8B1644F4-686C-4576-A765-E2281AB6BF81Q30381770-7E586471-1723-4BDF-A7FF-BE5307B7F64FQ30580997-D4A0A4FE-47B3-469F-950E-62A310B3A0FFQ30996886-84BD1569-E666-41B3-BD62-00A6A705AB09Q31035798-7519973D-3707-4962-B9A2-5A4BBF10B23BQ31123434-40FF98FF-1986-4189-A331-199AFCA804FEQ33684312-ADCC07AE-A1EA-4FB5-9FF6-0A075E9DB7AAQ33806002-E837BDDB-A690-49B1-A0CC-6E92EAE3C4A3Q34063022-374371A1-95C2-4A19-9226-A663ACF00312Q34105049-E7990C60-2679-4DCD-B0F7-27530453C884Q34149119-F17B76E7-528F-433C-BD4B-DF68C2B01E67Q34177747-31842204-E250-48CB-8FA9-3042DD8360FBQ34203601-11938390-856F-4CF2-83FC-0D552AE24000Q34296925-177203E2-6C74-43CE-8C9D-6A450DA15A87Q34348171-0EA6FAAC-79A4-42BD-80FB-8A849CEFC220Q34382670-115FA990-49E3-4AB6-A303-6075412D80EEQ34468955-D493E4CD-8A9C-4CD6-9AE4-03112E4AC7C4Q34482638-8BD63D69-99D7-4DC4-8BDD-744B6A63565EQ34494972-3E8DEEFC-06EF-4320-8C53-A121B7EF2A7EQ34550481-52185CD7-86BB-4A85-A095-347274D08DCEQ34587686-FAF9BD5E-6490-47A1-99E0-7B57FEC00DF6Q34675010-6EE890DE-6528-427E-A9A6-6A1EEAEB613BQ35142688-269C2B6A-E95D-475C-A7CC-A5DBFFCEA6C2Q35154001-6AE896CE-C2E4-4DE0-B646-D0689A6EE16BQ35657891-8B9FF530-EFA3-4DA7-97BF-0FBD9B6DA62CQ35661520-E8FF1F16-A409-4EE5-9639-F8433712CC21Q35674698-7A161734-A1D5-458A-AD05-E94240FC4A8EQ35932304-76542025-6E9C-4C1B-939D-8F3963FDD822Q36129712-007CC584-C22F-4688-9F8A-705F507C4D0FQ36248853-AAFC0AAE-5B3E-4A7F-B1E5-99C996DDB009Q36534466-2137CD57-8764-4CF7-B499-4BD014939E34
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Ecotoxicology of human pharmaceuticals.
@ast
Ecotoxicology of human pharmaceuticals.
@en
Ecotoxicology of human pharmaceuticals.
@nl
type
label
Ecotoxicology of human pharmaceuticals.
@ast
Ecotoxicology of human pharmaceuticals.
@en
Ecotoxicology of human pharmaceuticals.
@nl
prefLabel
Ecotoxicology of human pharmaceuticals.
@ast
Ecotoxicology of human pharmaceuticals.
@en
Ecotoxicology of human pharmaceuticals.
@nl
P2093
P1433
P1476
Ecotoxicology of human pharmaceuticals.
@en
P2093
Anna A Weston
Daniel Caminada
P304
P356
10.1016/J.AQUATOX.2005.09.009
P577
2005-10-27T00:00:00Z